MB
Insider
Michael Benkowitz
PRESIDENT AND COOMichael Benkowitz (PRESIDENT AND COO) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales, 3 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $14.2M of UTHR (30,214 sh across 13 lots, as filed), executed Jan 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
24
0 buys · 24 sells · 3 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$226.0M
shares × price, as filed
Last traded
Feb 23
Filed Feb 24
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $335.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
23 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$9.0M22,395 sh across 13 lots
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $6.3M
15,842 sh across 10 lots
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $9.1M
21,727 sh across 9 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $387K
1,207 sh across 3 lots
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET